Salivary Cancer
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers (NCT02749903) | Alliance for Clinical Trials in Oncology | 2016-09-14 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors (NCT02091141) | Genentech, Inc. | 2014-04-14 |
Track Salivary Cancer automatically
Every clearance here is in the API, with alerts when new ones post.